Samson Medical Technologies
Samson Medical Technologies, L.L.C. is a privately-held company focused on providing hospital and alternate site pharmacists.
- Company typePrivate
- Founded1999
- HeadquartersCherry Hill, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Samson Medical Technologies does
Samson Medical Technologies, L.L.C. is a privately-held US specialty pharmaceutical company headquartered in Cherry Hill, New Jersey, founded in 1999 and operating with 11-50 employees. The company is focused on providing hospital and alternate site pharmacists with injectable drug delivery systems and programs designed for sterile product preparation. Its business is built around a single proprietary platform — the SmartPak® patented dual-bag packaging system — and a narrow product portfolio of five sterile injectable antibiotic SKUs: Ceftriaxone 100g, Cefazolin 100g and 300g, Cefepime 100g, and Vancomycin Hydrochloride 100g.
The SmartPak® system consists of a sealed inner plastic bag containing up to 300 grams of sterile powder, enclosed in a four-layer laminated aluminum foil outer over-wrap. The inner additive-free polymer bag has two ports — one for diluent introduction and one for withdrawal of reconstituted doses — and a four-liter capacity that allows flexible concentration preparation. The outer foil bag protects the contents from light, moisture, and oxidation. The design is latex-free, preservative-free, and bar-coded, and is described as compatible with all infusion delivery systems, enabling single-operator closed-system reconstitution.
Samson sells directly to hospital pharmacy departments and alternate site healthcare providers (home infusion and specialty pharmacies) through a B2B website with registered/login-gated contract pricing, supplemented by phone-based ordering and customer service. No pricing is publicly disclosed. The company is founder-owned (Marvin Samson) with no disclosed institutional investors, no funding rounds, no acquisitions, and no international operations. Two named enterprise hospital customers (Kevin Kyle and Rich Paoletti) are cited publicly, with one customer reporting over 800,000 doses of IV sterile products reconstituted annually using SmartPak.
Samson Medical Technologies firmographics
Firmographics- Name
- Samson Medical Technologies
- Legal name
- Samson Medical Technologies, L.L.C.
- Website
- http://samsonmt.com/
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Samson Medical Technologies, L.L.C. is a privately-held company focused on providing hospital and alternate site pharmacists.
- Ownership category
- akta.pro rank
Samson Medical Technologies industry classification
Industry- Product category
- Pharmaceutical Packaging
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Pharmaceutical Preparations (2834), Plastics Products, Nec (3089)
- akta.pro primary industry
- Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers) (IMALAIAB)
- akta.pro secondary industries
- Parenteral & Injectable Packaging Components (Stoppers, Seals, Syringes, Cartridges) (IMALAIAE), Pharmaceutical & Medical Plastic Packaging Manufacturing (IMANAEAK)
Keywords
Where Samson Medical Technologies is headquartered
LocationHeadquarters
- HQ city
- Cherry Hill
- HQ country
- United States
- HQ region
- North America
Markets served
Samson Medical Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales
Samson Medical Technologies product offering
Product offeringCore offering
Samson Medical Technologies manufactures and sells the SmartPak® product family, a patented dual-bag closed packaging system for sterile injectable antibiotics. Each SmartPak® contains up to 300 grams of sterile powder in a sealed plastic bag enclosed in a foil over-wrap, designed for hospital and alternate site pharmacy reconstitution. The portfolio currently includes five bulk antibiotic SKUs: Ceftriaxone, Cefazolin (100g and 300g), Cefepime, and Vancomycin Hydrochloride.
Product overview
Samson Medical Technologies offers the SmartPak® product family, a patented injectable drug packaging system. The SmartPak® system consists of a sealed plastic bag containing up to 300 grams of sterile powder enclosed in a foil over-wrap. The portfolio includes five antibiotic products: Ceftriaxone 100g, Cefazolin 100g and 300g, Cefepime 100g, and Vancomycin Hydrochloride 100g. Each product features a dual-bag design with an inner additive-free polymer bag (with two ports and four-liter capacity) and an outer aluminum foil bag for light/moisture protection. The system is designed for hospital and alternate site pharmacists to improve sterility assurance, reduce manipulations, and increase operational efficiency in sterile product preparation.
Differentiator
Problem solved
Functional benefit
Brands
- SmartPak: A patented packaging system for injectable drugs - a sealed plastic bag containing up to 300 grams of sterile powder enclosed in a foil over-wrap, designed for sterile product preparation in hospital and alternate site pharmacies.
Products and services
- SmartPak® Ceftriaxone 100 grams Bulk antibiotic injectable drug containing 100 grams of sterile ceftriaxone powder packaged in the patented SmartPak dual-bag system, intended for hospital pharmacy bulk preparation of IV sterile products.
- SmartPak® Cefazolin 100 grams Bulk antibiotic injectable drug containing 100 grams of sterile cefazolin powder in SmartPak packaging, designed for hospital pharmacy sterile preparation workflows.
- SmartPak® Cefazolin 300 grams Bulk antibiotic injectable drug containing 300 grams of sterile cefazolin powder in SmartPak packaging, intended for hospital pharmacy bulk preparation of IV sterile products.
- SmartPak® Cefepime 100 grams Bulk antibiotic injectable drug containing 100 grams of sterile cefepime powder in SmartPak packaging, intended for hospital pharmacy sterile preparation.
- SmartPak® Vancomycin Hydrochloride 100 grams Bulk antibiotic injectable drug containing 100 grams of sterile vancomycin hydrochloride powder in SmartPak packaging, designed for hospital pharmacy sterile preparation.
Quantifiable outcome
- Over 800,000 doses of IV sterile products reconstituted annually per customer using SmartPak
Companies that use Samson Medical Technologies
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
Samson Medical Technologies technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Samson Medical Technologies partnerships and signals
Strategic signalRecent moves4 records
Expansion highlights2 records
Samson Medical Technologies competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key highlights6 records
Customer concentration
Samson Medical Technologies social profiles
Digital presenceSamson Medical Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Samson Medical Technologies leadership team
Management profileNumber of profiles
Profiles1 record
Samson Medical Technologies funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Samson Medical Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Samson Medical Technologies
What does Samson Medical Technologies do?
Samson Medical Technologies manufactures and sells the SmartPak® product family, a patented dual-bag closed packaging system for sterile injectable antibiotics. Each SmartPak® contains up to 300 grams of sterile powder in a sealed plastic bag enclosed in a foil over-wrap, designed for hospital and alternate site pharmacy reconstitution. The portfolio currently includes five bulk antibiotic SKUs: Ceftriaxone, Cefazolin (100g and 300g), Cefepime, and Vancomycin Hydrochloride.
Is Samson Medical Technologies a public or private company?
Samson Medical Technologies is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Samson Medical Technologies founded?
Samson Medical Technologies was founded in 1999. It employs 11 to 50 people.
Where is Samson Medical Technologies based?
Samson Medical Technologies is headquartered in Cherry Hill, United States, in the North America region.
Does Samson Medical Technologies have an API?
No public API is recorded for Samson Medical Technologies.
What industry is Samson Medical Technologies in?
Samson Medical Technologies's product category is Pharmaceutical Packaging. Its primary akta.pro industry code is IMALAIAB, Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers), with a secondary code of IMALAIAE, Parenteral & Injectable Packaging Components (Stoppers, Seals, Syringes, Cartridges). Its NAICS code is 325412 and its SIC code is 2834.